Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00935077 · ClinicalTrials.gov registry record · Phase 3
A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities
A Phase 3 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,441
- Enrollment target
NCT00935077 is a Phase 3 study that has completed, run by University of Iowa. The registered enrollment target is 1,441 participants.
The verdict
NCT00935077, a Phase 3 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,441 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the degree to which pharmacist-physician collaborative management (PPCM) of hypertension can be adopted and implemented in clinics with geographic and racial diversity and whether patients in clinics which implement PPCM achieve greater blood pressure control than patients in clinics which do not implement PPCM. Primary Hypothesis: BP control at 9 months will be significantly greater in patients from clinics randomized to the two PPCM BP intervention groups compared to the control group.
Interventions
- OTHER PPCM Asthma
- OTHER 24 Month PPCM BP
- OTHER 9 Month PPCM BP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,441 participants |
| Start Date | 2010-01 |
| Est. Completion | 2014-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00935077
The ClinicalTrials.gov registry entry for NCT00935077 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,441 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PPCM Asthma is the first listed.
NCT00935077 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00935077 about?
NCT00935077 is a clinical study titled "A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities". The purpose of the study is to determine the degree to which pharmacist-physician collaborative management (PPCM) of hypertension can be adopted and implemented in clinics with geographic and racial diversity and whether patients in clinics which implement PPCM achieve greater blood pressure control...
What is the current status of trial NCT00935077?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,441 participants. The study started on 2010-01. Estimated completion is 2014-03.
What interventions are being tested in trial NCT00935077?
The interventions under investigation include: PPCM Asthma (OTHER), 24 Month PPCM BP (OTHER), 9 Month PPCM BP (OTHER).
Who is sponsoring clinical trial NCT00935077?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.